Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

First dual SPK 1/2 inhibitors discovered at Amgen

May 2, 2012

Scientists in Japan present new agents active against drug-resistant HIV-1

May 2, 2012

Novel PLK1 inhibitor exhibits antitumor activity in vivo

April 30, 2012

Double-blind trial assesses extended-release once-daily epilepsy drug

April 30, 2012

Responses to sodium oxybate vary in phase I/II trial

April 30, 2012

Promising candidate biomarker of venous thrombosis uncovered

April 30, 2012

U.K. study reveals new potential marker of acute kidney injury in acute on chronic liver failure

April 30, 2012

Phase I trial tests once-daily and intermittent INK-128 dosing

April 27, 2012

Phase I data available on antisense drug for ALS

April 27, 2012

Phase I trial studies vandetanib combination therapy for brain cancer

April 27, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...